AI in clinical trials is advancing at breakneck speed, yet a hard truth remains: most healthcare systems aren't architecturally ready for it. While healthcare systems continue to invest in LLMs, generative AI, and predictive analytics, most organisations are discovering that innovation alone is not enough.
The Harsh Reality: Healthcare Data Is Still a Mess for AI in Clinical Trials
Nearly 80 percent of medical data in the U.S. is unstructured and largely unusable for advanced analytics or AI-driven insights, as much of it resides in free-text notes, imaging outputs, and other non-standard formats.
EHRs, EMRs, eClinical platforms, LIS and RIS systems, PACS, claims data, sensor streams, RPM feeds, and HIE inputs all sit in disconnected silos. This fragmented environment makes it difficult for AI in clinical trials to build consistent, high-quality patient profiles.
Why Fragmented Data Cripples Clinical AI in Trials
AI models cannot reach their full potential when they are trained on fragmented, outdated or inaccessible data. Strengthening data quality and flow is essential for AI in clinical trials to deliver the accuracy and trust that clinical environments require.
The Shift: From Model-First to Data-Backbone-First
Healthcare organizations are beginning to recognize that meaningful AI performance starts with strong data foundations, not complex algorithms. The focus has shifted toward improving data quality through normalization, governance, lineage and seamless integration long before any model is introduced.
Wrapping Up
The path forward for AI in clinical trials is clear: success will belong to the organizations that treat data as their most powerful asset. As healthcare systems continue to adopt advanced models and automation, it is the integrity, flow and context of the underlying data that will ultimately determine clinical impact.